Mpac Group Plc (AIM:MPAC) delivered its latest investor update highlighting resilient performance despite challenging US market conditions driven by tariffs. Revenue for the first half rose 41% to £84.7m, supported by strong contributions from the CSI acquisition, while underlying operating profit increased 67% to £7.5m, with gross margins up sharply to 36%. The order book stood at £91.7m, providing around 60% forward revenue cover, and management reaffirmed full year guidance. Mpac continues to expand its global footprint across food, beverage, and healthcare markets, serving blue-chip customers including Nestlé, Mars, and AstraZeneca. Strategic initiatives include consolidating US operations, expanding low-cost manufacturing in Romania, and opening a new engineering hub in Malaysia. Innovation remains central, with the Horizon machine winning a prestigious Red Dot design award and new product launches such as the Austro and Brisa cartoning systems driving customer engagement. The group also announced successful de-risking of its UK pension scheme through a £249m buy-in with Aviva, paving the way for a full buyout. With order intake diversification—42% from new customers—and strong service revenue growth, Mpac emphasized its competitive advantage through engineering expertise, high barriers to entry, and capital-light model. Despite near-term headwinds from deferred US capex, management highlighted robust demand fundamentals, a growing project pipeline, and opportunities for cross-selling across recently acquired businesses. Board strength was further enhanced with new non-executive appointments from leading UK listed companies. Overall, Mpac positions itself as a resilient, innovation-led packaging automation partner with clear long-term growth drivers, margin expansion, and a strong balance sheet to support its strategy.